Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Spruce Biosciences (SPRB) Long-Term Debt Repayments (2023 - 2025)

Spruce Biosciences (SPRB) has disclosed Long-Term Debt Repayments for 3 consecutive years, with $841000.0 as the latest value for Q4 2025.

  • Quarterly Long-Term Debt Repayments rose 107.14% to $841000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $2.1 million through Dec 2025, up 26.82% year-over-year, with the annual reading at $2.1 million for FY2025, 26.82% up from the prior year.
  • Long-Term Debt Repayments for Q4 2025 was $841000.0 at Spruce Biosciences, up from $405000.0 in the prior quarter.
  • The five-year high for Long-Term Debt Repayments was $841000.0 in Q4 2025, with the low at $405000.0 in Q1 2023.
  • Average Long-Term Debt Repayments over 3 years is $441750.0, with a median of $405500.0 recorded in 2023.
  • The sharpest move saw Long-Term Debt Repayments changed 0.0% in 2024, then soared 107.14% in 2025.
  • Over 3 years, Long-Term Debt Repayments stood at $406000.0 in 2023, then changed by 0.0% to $406000.0 in 2024, then surged by 107.14% to $841000.0 in 2025.
  • According to Business Quant data, Long-Term Debt Repayments over the past three periods came in at $841000.0, $405000.0, and $406000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.